Header image

Oral Presentations 21: Drug Disposition and Response 1

Tracks
Track 5
Wednesday, July 15, 2026
9:00 AM - 10:30 AM

Speaker

Agenda Item Image
Prof Janne Backman
University Of Helsinki

Black tea, but not cola, impairs the oral absorption of risperidone

Abstract

Biography

Agenda Item Image
Ms Shuang Lu
Fudan University

Mind the gap: unravelling the pharmacokinetic variability of medicinal cannabis

Abstract

Biography

Agenda Item Image
Prof Nan-lin Wu
Mackay Medical University/mackay Memorial Hospital

A real-world indirect comparison of risankizumab versus guselkumab for psoriasis patients

Abstract

Biography

Agenda Item Image
Ms Dominika Fuhs
Monash University

Ceftazidime/avibactam plus meropenem against ST235-clone Pseudomonas aeruginosa clinical isolates

Abstract

Biography

Dominika is a PhD candidate at the Monash Institute of Pharmaceutical Sciences. Her PhD research focuses on the development of novel mechanisms-based mathematical models that can describe and predict full time-courses of bacterial growth and resistance emergence to combat multidrug-resistant bacteria that can cause life-threatening infections. She’s passionate about investigating ways to treat resistant bacterial “superbugs” by optimising dosing regimens of currently available antibiotics in the fight against antimicrobial resistance."
Agenda Item Image
Assoc Prof Amedeo De Nicolò
Università Di Torino

Pharmacokinetics of Regorafenib and Temozolomide, alone or combined: a Phase-I study

Abstract

Biography

Agenda Item Image
Mr Yanbiao Liu
Auckland University Of Technology

SPAG5 knockout sensitises TNBC to docetaxel and ribociclib in vitro

Abstract

Biography

loading